Back to search

United Kingdom· GB-APID-31553311000001103

Kalydeco 50mg granules sachets

A ivacaftor product containing ivacaftor, registered in United Kingdom by Vertex Pharmaceuticals (Europe) Ltd. The same ATC class is registered in 17 of our 19 countries.

ATC R07AX02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedKalydeco 50mg granules sachetsATCR07AX02REGISTER NO.GB-APID-3155331100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Ivacaftor is registered in 17 of 19 countries.

Countries holding a registration under ATC R07AX02 (ivacaftor), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ivacaftor · ATC R07AX02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ivacaftor costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.03 in France to $1826.01 in Switzerland — a ×1781 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ivacaftor · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1826.01
  • IT Italy$1090.14
  • FR France$1.03
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ivacaftor
Manufacturer
Vertex Pharmaceuticals (Europe) Ltd
Country
United Kingdom (GB)
ATC code
R07AX02
ATC class
Ivacaftor
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    00351167130605
  • gtin
    00351167131008

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

469 interactions on record for ivacaftor.

Graded by severity as the source publishes them — 80 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ivacaftor · interactions on record

469 records

  • 80 severe
  • 373 moderate
  • 16 minor

Most severe, free to view

  • AprepitantA04AD12severe
  • LonafarnibA16AX20severe
  • EdoxabanB01AF03severe
  • BerotralstatB06AC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ivacaftor in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivacaftor products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ivacaftor Accord, Ivacaftor Stada
  • Belgium · Ivacaftor Ab, Ivacaftor Accord
  • Cyprus · Vaftor
  • Czechia · Ivacaftor Accord
  • Germany · Ivacaftor Al, Ivacaftor Basics
  • Denmark · Ivacaftor "stada", Ivacaftor Accord
  • Estonia · Ivacaftor Stada
  • Spain · Ivacaftor Accord, Ivacaftor Aurovitas
  • Finland · Ivacaftor Accord, Ivacaftor Stada Stada
  • France · Ivacaftor Accord, Ivacaftor Arrow
  • Greece · Ivacaftor Win Medica, Qulventra
  • Croatia · Ivacaftor Accord, Ivakaftor Galenika
  • Hungary · Ivacaftor Galenika, Ivacaftor Stada
  • Iceland · Kalydeco
  • Italy · Ivacaftor Accord, Ivacaftor Sun
  • Liechtenstein · Kalydeco
  • Lithuania · Ivacaftor Stada
  • Luxembourg · Ivacaftor Ab, Ivacaftor Eg
  • Latvia · Ivacaftor Stada, Ivacaftor Teva
  • Malta · Fidasercot, Flidepartoc
  • Netherlands · Ivacaftor Aurobindo, Ivacaftor Intas
  • Norway · Ivacaftor Accord, Ivacaftor Lupin Europe Gmbh
  • Poland · Ivacaftor Accord, Ivacaftor Ranbaxy
  • Portugal · Ivacaftor Accord, Ivacaftor Generis
  • Romania · Ivacaftor Stada, Ivacaftor Sun
  • Sweden · Fidasercot, Flidepartoc
  • Slovenia · Ivakaftor Accord, Ivakaftor Galenika

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59e64a1e-90e5-4313-b3e5-f06de68c65a9
GET /v1/drugs/59e64a1e-90e5-4313-b3e5-f06de68c65a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "31553311000001103",
  "desc": "Kalydeco 50mg granules sachets (Vertex Pharmaceuticals (Europe) Ltd)",
  "form": "Oral granules",
  "vpid": "31719211000001102",
  "source": "dmd",
  "vtm_id": "776434000",
  "strength": "50 mg",
  "substance": "Ivacaftor",
  "ingredient": "Ivacaftor",
  "supplier_code": "21148411000001105"
}

See everything about ivacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.